Angptl4 upregulates cholesterol synthesis in liver via inhibition of LPL- and HL-dependent hepatic cholesterol uptake

Lichtenstein, Laeticia, Berbée, Jimmy F P, van Dijk, Susan J, van Dijk, Ko Willems, Bensadoun, André, Kema, Ido P, Voshol, Peter J, Müller, Michael ORCID: https://orcid.org/0000-0002-5930-9905, Rensen, Patrick C N and Kersten, Sander (2007) Angptl4 upregulates cholesterol synthesis in liver via inhibition of LPL- and HL-dependent hepatic cholesterol uptake. Arteriosclerosis, Thrombosis, and Vascular Biology, 27 (11). pp. 2420-2427. ISSN 1079-5642

Full text not available from this repository. (Request a copy)

Abstract

Dysregulation of plasma lipoprotein levels may increase the risk for atherosclerosis. Recently, angiopoietin-like protein 4, also known as fasting-induced adipose factor Fiaf, was uncovered as a novel modulator of plasma lipoprotein metabolism. Here we take advantage of the fasting-dependent phenotype of Angptl4-transgenic (Angptl4-Tg) mice to better characterize the metabolic function of Angptl4.

Item Type:	Article
Uncontrolled Keywords:	angiopoietins,animals,biosynthetic pathways,blood glucose,blood proteins,cholesterol,fasting,fatty acids,insulin resistance,lipolysis,lipoprotein lipase,liver,mice,mice, transgenic,triglycerides
Faculty \ School:	Faculty of Medicine and Health Sciences > Norwich Medical School
UEA Research Groups:	Faculty of Medicine and Health Sciences > Research Groups > Nutrition and Preventive Medicine Faculty of Medicine and Health Sciences > Research Groups > Gastroenterology and Gut Biology
Depositing User:	Pure Connector
Date Deposited:	21 Feb 2014 11:50
Last Modified:	24 Oct 2022 06:08
URI:	https://ueaeprints.uea.ac.uk/id/eprint/47725
DOI:	10.1161/ATVBAHA.107.151894

Actions (login required)

View Item